MYELOMA
Clinical trials for MYELOMA explained in plain language.
Never miss a new study
Get alerted when new MYELOMA trials appear
Sign up with your email to follow new studies for MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered t cells take on Hard-to-Treat blood cancers
Disease control OngoingThis study tests a new treatment for people with certain blood cancers (lymphoma, multiple myeloma, or CLL) that have returned or not responded to standard therapy. Researchers take a patient's own immune cells (T cells) and modify them in the lab to better recognize and attack c…
Matched conditions: MYELOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
New hope for elderly myeloma patients: drug combo aims to deepen remission without transplant
Disease control OngoingThis phase 3 study tests whether adding the drug isatuximab to a standard two-drug regimen (lenalidomide and dexamethasone) works better with or without a third drug (bortezomib) for newly diagnosed multiple myeloma. The study includes 270 non-frail patients aged 65 to 79 who are…
Matched conditions: MYELOMA
Phase: PHASE3 • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New drug combo aims to deepen remission in multiple myeloma patients
Disease control OngoingThis study tests whether adding the drug belantamab mafodotin before and after a stem cell transplant can help people with multiple myeloma achieve deeper remission. About 41 adults who have started treatment within the past year will receive the drug alongside standard care. The…
Matched conditions: MYELOMA
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 26, 2026 05:52 UTC
-
Shorter chemo cycles may keep myeloma in check longer
Disease control OngoingThis study tests a different way of giving chemotherapy to people with multiple myeloma who have already received some treatment but not a transplant. The goal is to give lower doses in shorter cycles so that cancer cells have less time to grow back between treatments. Researcher…
Matched conditions: MYELOMA
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New Shot-Based myeloma treatment shows promise in early trial
Disease control OngoingThis study tests a new way to give the drug isatuximab as a quick shot under the skin, instead of a long IV drip, for people newly diagnosed with multiple myeloma who cannot have a stem cell transplant. The treatment combines isatuximab with three standard chemotherapy drugs (bor…
Matched conditions: MYELOMA
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Powerful 4-Drug cocktail shows promise against bone marrow cancer
Disease control OngoingThis study tests a combination of four drugs (daratumumab, carfilzomib, lenalidomide, and dexamethasone) as the first treatment for people newly diagnosed with multiple myeloma, a type of blood cancer. The goal is to see how well the treatment works at eliminating cancer cells an…
Matched conditions: MYELOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New imaging agent could light up tumors for better cancer detection
Knowledge-focused OngoingThis early-phase study is testing a tiny amount of a new drug called 124I-PUH71 in 63 people with certain cancers (lymphoma, myeloma, or solid tumors). The goal is not to treat the cancer, but to see how the drug spreads through the body and collects in tumors, and how long it st…
Matched conditions: MYELOMA
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC